$1.24
0.043.33%
Last update: Oct 30, 4:25 PM
Pluri Inc (PLUR) Stock Price, Quote, News & History
PLURNASDAQ
Pluri Inc. (NASDAQ: PLUR) has signed a three-year, $4.2 million contract with the U.S.
You can purchase shares of Pluri (NASDAQ:PLUR) through any online brokerage.
Other companies in Pluri’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Pluri has a consensus price target of $12.00.
The stock price for Pluri (NASDAQ: PLUR) is $1.22 last updated October 30, 2026 at 4:25 PM EDT.
There are no upcoming dividends for Pluri.
Pluri does not have any upcoming earnings scheduled.
There is no upcoming split for Pluri.
Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of...
